Case Report: a rare pediatric case series of multiple endocrine neoplasia type 2B presenting with laryngotracheal involvement.
This two-patient pediatric case series reports laryngotracheal mucosal neuromas causing obstruction and progressive respiratory compromise as the initial presentation of RET mutation-confirmed MEN2B.
Open original publication →What the AI sees
This two-patient pediatric case series reports laryngotracheal mucosal neuromas causing obstruction and progressive respiratory compromise as the initial presentation of RET mutation-confirmed MEN2B.
Research significance
The reported cases support airway evaluation and prompt RET testing when children with obstruction also have MEN2B-associated phenotypic or familial features; it is an inference, not tested here, that earlier recognition and multidisciplinary management could accelerate MEN2B-directed surveillance and treatment and reduce airway morbidity.
Source abstract
BACKGROUND: Multiple endocrine neoplasia type 2B (MEN2B) is a rare autosomal dominant genetic disorder caused by activating germline mutations in the RET proto-oncogene, typically arising during embryogenesis. The syndrome is characterized by the coexistence of medullary thyroid carcinoma, pheochromocytoma, gastrointestinal ganglioneuromas, and diffuse mucosal neuromas, the latter representing a pathognomonic clinical feature. In pediatric patients, mucosal neuromas most commonly involve the oral cavity, whereas laryngeal or other airway involvement is exceedingly rare and often underrecognized. METHODS: From 2013 to 2025, two pediatric patients diagnosed with MEN2B were identified at our center. Both cases were confirmed to harbor pathogenic RET gene mutations by genetic testing. RESULT: In this study, we describe two pediatric cases of MEN2B in which laryngeal obstruction and progressive respiratory compromise were the initial clinical manifestations. Laryngoscope and CT examinations revealed mucosal neuromas within the laryngotracheal airway, and postoperative histopathology confirmed the diagnosis of neuroma. We further review the available literature on laryngotracheal involvement in MEN2B to elucidate its phenotypic spectrum and clinical implications. Timely recognition through detailed phenotypic assessment, molecular confirmation of RET mutations, and multidisciplinary management is essential to optimize outcomes. CONCLUSION: Laryngeal or airway neuromas are extremely rare. Clinicians should maintain a high index of suspicion for laryngeal neuromas in children presenting with characteristic craniofacial dysmorphism or a family history suggestive of endocrine neoplasia, as prompt genetic evaluation and integrated management may be life-saving.